US Stock MarketDetailed Quotes

AGRX Agile Therapeutics

Watchlist
  • 1.450
  • +0.010+0.69%
15min DelayClose Jul 26 16:00 ET
10.01MMarket Cap-2788P/E (TTM)

Agile Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Agile Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

5.72M

+49.91%
EPS(YoY)

0.28

+104.74%
Analyst Rating

No Data

Agile Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Mar 28, 20242023/Q43.615M / 4.069M--
Nov 9, 20232023/Q36.662M / 6.353M--
Aug 9, 20232023/Q25.503M / 4.627M--
May 11, 20232023/Q13.813M / 3.397M--
Mar 22, 20232022/Q43.996M / 3.125M--
DatePeriodRevenue/EstimateEarnings Call
Mar 28, 20242023/Q43.615M / 4.069M--
Nov 9, 20232023/Q36.662M / 6.353M--
Aug 9, 20232023/Q25.503M / 4.627M--
May 11, 20232023/Q13.813M / 3.397M--
Mar 22, 20232022/Q43.996M / 3.125M--

Unlock Free Earnings Estimates

Agile Therapeutics Earnings Reports

  • 10-Q: Quarterly report

    May 15 16:55 ET

  • 10-K/A: Annual report (Amendment)

    Apr 29 16:38 ET

  • Agile Therapeutics | 10-K: Annual report

    Mar 28 22:24 ET

  • Agile Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:30 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg